Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua
N Engl J Med
.
2022 Aug 11;387(6):568-570.
doi: 10.1056/NEJMc2203985.
Epub 2022 Jul 20.
Authors
Hannah E Maier
1
,
Angel Balmaseda
2
,
Saira Saborio
3
,
Sergio Ojeda
2
,
Carlos Barilla
2
,
Nery Sanchez
2
,
Roger Lopez
3
,
Miguel Plazaola
2
,
Cristhiam Cerpas
3
,
Harm van Bakel
4
,
John Kubale
1
,
Eva Harris
5
,
Guillermina Kuan
2
,
Aubree Gordon
6
Affiliations
1
University of Michigan, Ann Arbor, MI.
2
Sustainable Sciences Institute, Managua, Nicaragua.
3
Ministry of Health, Managua, Nicaragua.
4
Icahn School of Medicine at Mount Sinai, New York, New York.
5
University of California, Berkeley, Berkeley, CA.
6
University of Michigan, Ann Arbor, MI
[email protected]
.
PMID:
35857652
PMCID:
PMC9342422
DOI:
10.1056/NEJMc2203985
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Antibodies, Viral* / immunology
COVID-19* / immunology
Humans
Immunity, Active* / immunology
Nicaragua / epidemiology
SARS-CoV-2
Substances
Antibodies, Viral
Grants and funding
HHSN272201400006C/AI/NIAID NIH HHS/United States
R01 AI120997/AI/NIAID NIH HHS/United States
S10 OD026880/OD/NIH HHS/United States
S10 OD030463/OD/NIH HHS/United States